GlassScript

Biosense Webster, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$20Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
10,868clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.9M
2020 $1.4M
2021 $1.9M
2022 $2.2M
2023 $2.4M
2024 $3.1M
2025 $7.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Clinical Cardiac Electrophysiology $15M
Cardiovascular Disease $2.7M
Internal Medicine $296K
Interventional Cardiology $264K
Neurological Surgery $170K
Family $153K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Rahul Bhardwaj Loma Linda, CA Clinical Cardiac Electrophysiology $540,142.95
Elad Anter Boston, MA Clinical Cardiac Electrophysiology $449,983.15
Koonlawee Nademanee Los Angeles, CA Clinical Cardiac Electrophysiology $433,532.75
Jonathan Hsu San Diego, CA Clinical Cardiac Electrophysiology $405,458.93
Luigi Di Biase Bronx, NY Cardiovascular Disease $397,030.02
Brett Gidney Santa Barbara, CA Clinical Cardiac Electrophysiology $316,111.12
Samuel Asirvatham Rochester, MN Clinical Cardiac Electrophysiology $278,626.27
Jason Zagrodzky Austin, TX Clinical Cardiac Electrophysiology $275,824.15
Jonathan Dukes Ventura, CA Clinical Cardiac Electrophysiology $253,852.78
Jose Osorio Filho Miami, FL Clinical Cardiac Electrophysiology $244,426.98

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.